Actinium Pharmaceuticals, Inc. (ATNM)

Operating Expenses

$25.93M

TTM · Period ending: · USD

ATNM logo

ATNM Operating Expenses

Latest reported$25.93M
ATNM TTM Operating Expenses ($11.56K → $25.93M)
High-resolution chart · PNG

ATNM operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Actinium Pharmaceuticals, Inc. Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
25,929,000
25,997,000
36,952,000
37,224,000
43,841,000
48,567,000
41,310,000
44,234,000
45,986,000
49,190,000
51,393,000
52,298,000
47,770,000
40,052,000
34,435,000
31,239,000
28,318,000
25,944,000
25,971,000
24,472,000
23,383,000
22,704,000
22,393,000
20,487,114
21,526,114
21,950,114
21,966,114
23,801,000
23,346,000
23,173,000
23,828,000
22,671,000
23,169,000
25,459,000
26,911,000
28,531,000
28,937,000
28,652,000
26,848,000
24,941,000
22,480,000
22,967,000
24,831,000
26,784,000
29,189,000
26,209,000
22,481,000
17,092,000
11,656,000
8,707,000
6,588,000
13,036,000
13,826,000
13,189,339
12,175,659
4,244,803
1,848,233
1,012,255
9,615
15,240
20,752
21,572
25,405
24,950
19,240
17,170
14,535
14,537
14,399
20,592
26,419
24,603
27,162
21,698
11,558
14,562
19,939
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.